Janssen vaccine maker considers closing Bern factory
Select your language
Generated with artificial intelligence.
Listening:
Janssen vaccine maker considers closing Bern factory
Vaccine developer Janssen is considering closing its factory in the Swiss capital Bern. On Tuesday it opened a consultation procedure with employees to find alternatives. Up to 300 employees could be affected by a plant closure.
+Get the most important news from Switzerland in your inbox
The subsidiary of US pharmaceutical giant Johnson & Johnson said on Tuesday that it was considering closing the Bern plant for two reasons. Firstly, a new vaccine designed to prevent colibacillus infections is not as effective as hoped.
Secondly, the production of lentiviral vectors will soon cease in Bern. The global company Johnson & Johnson is about to inaugurate a new, much larger plant in the Netherlands, according to a press release.
The factory that houses Janssen’s operations in Bern has a long history. It was founded in 1898 as the Swiss Institute of Serotherapy and Vaccination.
Translated from German by DeepL/jdp
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.